Abstract:Terminal α-2,6-sialylation of N-glycans is a humanized glycosylation that affects the properties and efficacy of therapeutic glycoproteins. Fc di-sialylation (a biantennary N-glycan with two α-2,6-linked sialic acids) of IgG antibodies imparts them with enhanced anti-inflammatory activity and other roles. However, the microheterogeneity of N-glycoforms presents a challenge for therapeutic development. Therefore, controlled sialylation has drawn considerable attention, but direct access to well-defined di-sialylated antibodies remains limited. Herein, a one-pot three-enzyme protocol was developed by engineering a bacterial sialyltransferase to facilitate the modification of therapeutic antibodies with N-acetylneuraminic acid or its derivatives towards optimized glycosylation. To overcome the low proficiency of bacterial sialyltransferase in antibody remodeling, the Photobacterium sp. JT-ISH-224 α-2,6-sialyltransferase (Psp2,6ST) was genetically engineered by terminal truncation and site-directed mutagenesis based on its protein crystal structure. With the optimized reaction conditions and using activity-based screening of various Psp2,6ST variants, a truncated mutant Psp2,6ST (111-511)-His6 A235M/A366G was shown to effectively improve the catalytic efficiency of antibody di-sialylation. Herceptin and the donor substrate promiscuity allow the introduction of bioorthogonal modifications of N-acetylneuraminic acid into antibodies for site-specific conjugation. 2-AB hydrophilic interaction chromatography analysis of the released N-glycans and intact mass characterization confirmed the high di-sialylation of Herceptin via the optimized one-pot three-enzyme reaction. This study established a versatile enzymatic approach for producing highly di-sialylated IgG antibodies. It provides new insights into engineering bacterial sialyltransferase for adaptation to the enzymatic glycoengineering of therapeutic antibodies and the glycosite-specific conjugation of antibodies.

Redox-Controlled Site-Specific Alpha 2-6-Sialylation

Successfully Engineering a Bacterial Sialyltransferase for Regioselective Α2,6-Sialylation

Synthesis Of Biologically Active N- And O-Linked Glycans With Multisialylated Poly-N-Acetyllactosamine Extensions Using P. Damsela Alpha 2-6 Sialyltransferase

Improved Α-Sialylation Through the Synergy of 5-N,4-o-oxazolidinone Protection and Exocyclic C-1 Neighboring Group Participation

Direct, Stereoselective Thioglycosylation Enabled by an Organophotoredox Radical Strategy.

A Redox‐Controlled Substrate Engineering Strategy for Site‐Specific Enzymatic Fucosylation

ChemInform Abstract: Chemoenzymatic Synthesis of Sialosides and Their Applications

Characterization and application of active human α2,6-sialyltransferases ST6GalNAc V and ST6GalNAc VI recombined in Escherichia coli

Efficient chemoenzymatic synthesis of sialyl Tn-antigens and derivatives.

Tunable Stereoselectivity During Sialylation Using an N-acetyl-5-N,4-O-oxazolidinone-protected P-Toluene 2-Thio-sialoside Donor with Tf2O/Ph2SO/TTBPy

9-Azido Analogues of Three Sialic Acid Forms for Metabolic Remodeling of Cell-Surface Sialoglycans

Engineering a Bacterial Sialyltransferase for Di-Sialylation of a Therapeutic Antibody

Efficient Strategy for Α-Selective Glycosidation of D-Glucosamine and Its Application to the Synthesis of a Bacterial Capsular Polysaccharide Repeating Unit Containing Multiple Α-Linked GlcNAc Residues

Sialidase Substrate Specificity Studies Using Chemoenzymatically Synthesized Sialosides Containing C5-modified Sialic Acids

Enzyme-Sialylation-Controlled Chemical Sulfation of Glycan Epitopes for Decoding the Binding of Siglec Ligands

Non-enzymatic Stereoselective S-glycosylation of Polypeptides and Proteins

Reprogramming the Enzymatic Assembly Line for Site-Specific Fucosylation

A Radical Activation Strategy for Versatile and Stereoselective N‐Glycosylation

Site‐Specific Protein Modification with Reducing Carbohydrates

Stereospecific Synthesis and Biological Evaluation of KRN7000 Analogues with Thio-modifications at the Acyl Moiety

Efficient Synthesis of a Sialic Acid α(2→3)Galactose Building Block and Its Application to the Synthesis of Ganglioside GM3